66.82USDMkt Cap: 2.55B USDP/E: —Last update: 2026-05-22
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hemato…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap2.55B USD
Enterprise Value1.87B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-212.18M USD
Revenue/Share—
Last Price66.82 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees154
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.94
PEG—
EV/EBITDA-7.05
EV/Revenue—
P/S—
P/B3.72
EPS (TTM)-6.64
EPS (Forward)-7.50
52W Range
66.676% of range69.31
52W High69.31 USD
52W Low66.67 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-28.68%
ROA-26.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-180.39M USD
CapEx (TTM)933.00K USD
FCF Margin—
FCF Yield-4.76%
Net Debt-699.10M USD
Net Debt/EBITDA2.64
Balance Sheet
Debt/Equity0.04
Current Ratio24.00
Quick Ratio23.45
Book Value/Sh18.03 USD
Cash/Share19.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateDec 30, 2022
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)101.09 USD
Target Range79.00 USD – 128.00 USD
# Analysts11
Ownership
Shares Out.38.20M
Float32.75M
Insiders7.78%
Institutions113.61%
Short Interest
Short Ratio13.8d
Short % Float16.92%
Short % Out.14.50%
Shares Short5.54M
Short (prev mo.)5.46M
Technical
SMA 5065.79 (+1.6%)
SMA 20072.25 (-7.5%)
Beta2.14
S&P 52W Chg28.31%
Avg Vol (30d)216.31K
Avg Vol (10d)606.83K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—